498 related articles for article (PubMed ID: 26032184)
1. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
2. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
3. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
[TBL] [Abstract][Full Text] [Related]
4. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
7. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
[TBL] [Abstract][Full Text] [Related]
8. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
10. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic and clinical analysis of -7/7q- abnormalities in acute leukemia and myelodysplastic syndrome].
Meng HT; Mai WY; Chen ZM; Lou JY; Jin J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):460-3. PubMed ID: 15363131
[TBL] [Abstract][Full Text] [Related]
12. [Rearrangements of chromosome 9 in different hematological neoplasia].
Andreeva SV; Drozdova VD; Ponochevnaia EV; Kavardakova NV
Tsitol Genet; 2008; 42(5):72-9. PubMed ID: 19140443
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
14. [Chromosomal abnormalities in malignant hematologic diseases].
Rojas A; Pineda L; González S; Soto M; Avila E; Urdaneta B; Prieto-Carrasquero M; González R
Acta Cient Venez; 2000; 51(2):109-14. PubMed ID: 11155855
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and cytogenetic features of hematologic malignancies associated with acquired trisomy 21].
Wang H; Ni W; Chen Z; Lou J; Xu H; Yu Y; Qian W; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):576-8. PubMed ID: 18841576
[TBL] [Abstract][Full Text] [Related]
16. Hematological malignancies with t(9;11)(p21-22;q23)--a laboratory and clinical study of 125 cases. European 11q23 Workshop participants.
Swansbury GJ; Slater R; Bain BJ; Moorman AV; Secker-Walker LM
Leukemia; 1998 May; 12(5):792-800. PubMed ID: 9593283
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
18. 11q23 abnormalities in adult Chinese patients with hematological malignancies.
Zhao X; Li S; Li N; Fan R; Lin G; Wang X
Med Oncol; 2014 Aug; 31(8):115. PubMed ID: 25008067
[TBL] [Abstract][Full Text] [Related]
19. Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.
Wanquet A; Prebet T; Berthon C; Sebert M; Roux C; Kulasekararaj A; Micol JB; Esterni B; Itzykson R; Thepot S; Recher C; Delaunay J; Dreyfus F; Mufti G; Fenaux P; Vey N
Am J Hematol; 2015 Oct; 90(10):859-63. PubMed ID: 26113240
[TBL] [Abstract][Full Text] [Related]
20. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
